AXA S.A. – Regeneron Pharmaceuticals, Inc. Transaction History
AXA S.A. portfolio value:
$86.96M
portfolio value
AXA S.A. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.68% | -4.81K shares | 9.49M | $688.87 | 126.24K |
| Q2 2022 | share | Decrease | -2.66% | -3.57K shares | -16.55M | $591.13 | 131.06K |
| Q1 2022 | share | Decrease | -21.30% | -36.43K shares | -14.00M | $698.42 | 134.64K |
| Q4 2021 | share | Decrease | -13.19% | -26.00K shares | -11.23M | $642.51 | 171.07K |
| Q3 2021 | share | Increase | +61.04% | 74.69K shares | 50.91M | $605.18 | 197.07K |
| Q2 2021 | share | Decrease | -11.34% | -15.65K shares | 3.04M | $558.54 | 122.38K |
| Q1 2021 | share | Increase | +11.82% | 14.59K shares | 5.67M | $473.14 | 138.03K |
| Q4 2020 | share | Decrease | -1.59% | -1.99K shares | -10.58M | $483.11 | 123.44K |
| Q3 2020 | share | Increase | +6.72% | 7.89K shares | -3.08M | $559.78 | 125.43K |
| Q2 2020 | share | Increase | +41.04% | 34.20K shares | 32.61M | $623.65 | 117.54K |
| Q1 2020 | share | Decrease | -11.13% | -10.43K shares | 5.48M | $488.29 | 83.34K |
| Q4 2019 | share | Increase | +95.26% | 45.75K shares | 21.88M | $375.48 | 93.77K |
| Q3 2019 | share | Decrease | -3.71% | -1.85K shares | -2.28M | $277.4 | 48.02K |
| Q2 2019 | share | Decrease | -30.88% | -22.27K shares | -14.01M | $313 | 49.87K |
| Q1 2019 | share | Increase | +1.94% | 1.37K shares | 3.19M | $410.62 | 72.15K |
| Q4 2018 | share | Decrease | -23.88% | -22.20K shares | -11.13M | $373.5 | 70.78K |
| Q3 2018 | share | 0.00% | 0 shares | 5.49M | $404.04 | 92.98K | |
| Q2 2018 | share | Increase | +1.20% | 1.10K shares | 438K | $344.99 | 92.98K |
| Q1 2018 | share | Decrease | -1.39% | -1.29K shares | -3.39M | $344.36 | 91.88K |
| Q4 2017 | share | Decrease | -0.30% | -283 shares | -6.75M | $375.96 | 93.17K |
| Q3 2017 | share | Decrease | -16.49% | -18.45K shares | -13.17M | $447.12 | 93.46K |
| Q2 2017 | share | Increase | +37.92% | 30.76K shares | 23.52M | $491.14 | 111.91K |
| Q1 2017 | share | Decrease | -5.87% | -5.05K shares | -200K | $387.51 | 81.14K |
| Q4 2016 | share | Decrease | -15.87% | -16.26K shares | -9.55M | $367.09 | 86.19K |
| Q3 2016 | share | Increase | +0.05% | 50 shares | 5.42M | $402.02 | 102.46K |
| Q2 2016 | share | Decrease | -3.40% | -3.60K shares | -2.44M | $349.23 | 102.41K |
| Q1 2016 | share | Increase | +0.64% | 677 shares | -18.97M | $360.44 | 106.02K |